Dimensional Fund Advisors
PRME icon

Dimensional Fund Advisors’s Prime Medicine PRME Stock Holding History

Dimensional Fund Advisors’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.12M Buy
304,678
+156
+0.1% +$518 ﹤0.01% 2844
2026
Q1 		$1.06M Buy
304,522
+220,468
+262% +$839K ﹤0.01% 2831
2025
Q4 		$292K Buy
+84,054
New +$374K ﹤0.01% 3047

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Dimensional Fund Advisors's PRME Position: Q2 2026 in Review

Dimensional Fund Advisors increased its Prime Medicine (PRME) stake by 0.05% in Q2 2026, buying an estimated $518 and bringing the position to 304,678 shares worth $1.12M. The position accounts for ﹤0.01% of the portfolio, ranked #2844.

Dimensional Fund Advisors first reported a position in PRME in Q4 2025 and has held it in 3 quarters since. 187 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • Dimensional Fund Advisors held 304,678 shares of Prime Medicine worth $1.12M as of Q2 2026.
  • Dimensional Fund Advisors bought 156 Prime Medicine shares in Q2 2026, an estimated $518.
  • Prime Medicine made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2844 holding.
  • Dimensional Fund Advisors first reported a position in Prime Medicine in Q4 2025 and has held it in 3 quarters since.
  • 187 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.